Bharat Biotech to begin Phase-1 trials of its intranasal vaccine for COVID-19 in Feb-March https://ift.tt/eA8V8J

An intranasal vaccine will not only be simple to administer; it can also significantly impact the overall cost of a vaccination drive

from The Hindu - National https://ift.tt/2L63wL0